Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.

SZSE:301093 Voorraadrapport

Marktkapitalisatie: CN¥3.2b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Jiangsu Hualan New Pharmaceutical MaterialLtd Dividend

Dividend criteriumcontroles 3/6

Jiangsu Hualan New Pharmaceutical MaterialLtd is a dividend paying company with a current yield of 2.43% that is well covered by earnings.

Belangrijke informatie

2.4%

Dividendrendement

82%

Uitbetalingsratio

Gemiddelde opbrengst industrie1.4%
Volgende betaaldatum dividendn/a
Ex-dividenddatumn/a
Dividend per aandeelCN¥0.600
Winst per aandeelCN¥0.74
Dividendrendementsvoorspellingn/a

Recente dividendupdates

Recent updates

Weak Statutory Earnings May Not Tell The Whole Story For Jiangsu Hualan New Pharmaceutical MaterialLtd (SZSE:301093)

Sep 03
Weak Statutory Earnings May Not Tell The Whole Story For Jiangsu Hualan New Pharmaceutical MaterialLtd (SZSE:301093)

Is Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. (SZSE:301093) Trading At A 36% Discount?

Jun 07
Is Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. (SZSE:301093) Trading At A 36% Discount?

Stabiliteit en groei van betalingen

Dividenden ophalen

Stabiel dividend: 301093 has been paying a dividend for less than 10 years and during this time payments have been volatile.

Groeiend dividend: 301093 has only been paying a dividend for 2 years, and since then payments have fallen.


Dividendrendement versus markt

Jiangsu Hualan New Pharmaceutical MaterialLtd Dividendrendement versus markt
Hoe verhoudt 301093 dividendrendement zich tot de markt?
SegmentDividendrendement
Bedrijf (301093)2.4%
Markt onderkant 25% (CN)0.6%
Markt Top 25% (CN)2.2%
Gemiddelde industrie (Medical Equipment)1.4%
Analist prognose (301093) (tot 3 jaar)n/a

Opmerkelijk dividend: 301093's dividend (2.43%) is higher than the bottom 25% of dividend payers in the CN market (0.58%).

Hoog dividend: Het dividend van 301093 ( 2.43% ) behoort tot de top 25% van dividendbetalers in de CN markt ( 2.21% )


Winstuitkering aan aandeelhouders

Verdiendekking: At its current payout ratio (82.4%), 301093's payments are covered by earnings.


Contante uitbetaling aan aandeelhouders

Kasstroomdekking: With its high cash payout ratio (2215.7%), 301093's dividend payments are not well covered by cash flows.


Ontdek bedrijven met een sterk dividend